Pill Identifier Excedrin Pm Triple Action Caplets And Excedrin Tension Headache - NDC 0067-8147
Acetaminophen, Aspirin (nsaid), Caffeine, And Diphenhydramine Citrate
Product Code 0067-8147
Excedrin Pm Triple Action Caplets And Excedrin Tension Headache by Glaxosmithkline Consumer Healthcare Holdings (us) Llc is a blue rectangle kit about 17 mm in size, imprinted with expm. The product is a human otc drug with active ingredient(s) acetaminophen, aspirin (nsaid), caffeine, and diphenhydramine citrate.
Excedrin Pm Triple Action Caplets And Excedrin Tension Headache
Active Ingredient(s): Acetaminophen, Aspirin (nsaid), Caffeine, And Diphenhydramine Citrate
Inactive Ingredient(s):
- BENZOIC ACID
- CALCIUM CARBONATE
- FD&C BLUE NO. 1
- LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED
- HYPROMELLOSE, UNSPECIFIED
- MAGNESIUM STEARATE
- MALTODEXTRIN
- MEDIUM-CHAIN TRIGLYCERIDES
- POLYDEXTROSE
- POLYSORBATE 80
- POVIDONE, UNSPECIFIED
- STARCH, CORN
- MICROCRYSTALLINE CELLULOSE
- STEARIC ACID
- TALC
- TITANIUM DIOXIDE
- FERRIC OXIDE YELLOW
- ZINC STEARATE
Glaxosmithkline Consumer Healthcare Holdings (us) Llc
Product Type: Human Otc Drug
Dosage Form: Kit
- Blue (C48333)
Product Packages
NDC Package Code | Package Description |
---|---|
0067-8147-01 | 1 KIT in 1 PACKAGE, COMBINATION * 1 BOTTLE in 1 CARTON (0067-2056-24) > 24 TABLET, COATED in 1 BOTTLE * 1 BOTTLE in 1 CARTON (0067-8139-02) > 100 TABLET, FILM COATED in 1 BOTTLE |
* Please review the disclaimer below.
Pill Identification data last updated on: December, 2018
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. If this is an emergency, call 911 or the national Poison Help hotline at 1-800-222-1222. Most images are not part of the product labels and have not been verified by the labeler company. ALWAYS consult your physician or pharmacist with any medication-related questions.